| 11/16/2026 11:08 AM | ARMISTICE CAPITAL, LLC (1601086) Filed by Estrella Immunopharma (1844417) Subject | Form SCHEDULE 13G | |
| 11/13/2026 8:28 PM | Estrella Immunopharma (1844417) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/04/2026 6:23 AM | Estrella Immunopharma (1844417) Issuer Pussinen Cynthia (2163153) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/03/2026 10:03 AM | Estrella Immunopharma (1844417) Issuer Pussinen Cynthia (2163153) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 10/29/2026 4:28 PM | Estrella Immunopharma (1844417) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/08/2026 4:25 PM | Estrella Immunopharma (1844417) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/26/2026 6:23 PM | Estrella Immunopharma (1844417) Issuer Liu Cheng (1996255) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/25/2026 8:55 PM | Estrella Immunopharma (1844417) Issuer Xu Jiandong (1920399) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/21/2026 4:00 PM | Estrella Immunopharma (1844417) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/14/2026 9:11 AM | ARMISTICE CAPITAL, LLC (1601086) Filed by Estrella Immunopharma (1844417) Subject | Form SCHEDULE 13G/A | |
| 08/13/2026 4:01 PM | Estrella Immunopharma (1844417) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for ESLA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter.
|
| 06/30/2026 4:29 PM | Estrella Immunopharma (1844417) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/27/2026 4:25 PM | Estrella Immunopharma (1844417) Filer | Form DEF 14A | |
| 05/15/2026 8:24 PM | Estrella Immunopharma (1844417) Filer | Form NT 10-Q | |
| 05/15/2026 8:26 PM | Estrella Immunopharma (1844417) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/15/2026 10:16 AM | ARMISTICE CAPITAL, LLC (1601086) Filed by Estrella Immunopharma (1844417) Subject | Form SCHEDULE 13G | |
| 04/30/2026 4:27 PM | Estrella Immunopharma (1844417) Filer | Form 10-K/A | |
| 04/29/2026 8:36 PM | Estrella Immunopharma (1844417) Issuer Xu Jiandong (1920399) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/13/2026 4:28 PM | Estrella Immunopharma (1844417) Filer | Form 424B3 | |
| 01/25/2026 11:15 PM | Estrella Immunopharma (1844417) Filer | Form EFFECT | |
| 01/21/2026 7:51 PM | Estrella Immunopharma (1844417) Filer | Form S-1/A | |
| 01/16/2026 4:08 PM | Estrella Immunopharma (1844417) Filer | Form S-1/A | |
| 01/13/2026 4:21 PM | Estrella Immunopharma (1844417) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/06/2026 12:56 PM | Estrella Immunopharma (1844417) Filer | Form 424B5 | |
| 12/22/2025 9:56 AM | Estrella Immunopharma (1844417) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 12/04/2025 8:21 AM | Estrella Immunopharma (1844417) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |